KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Net Income towards Common Stockholders: 2017-2025

Historic Net Income towards Common Stockholders for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$92.7 million.

  • Guardant Health's Net Income towards Common Stockholders rose 13.95% to -$92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$398.8 million, marking a year-over-year increase of 22.17%. This contributed to the annual value of -$436.4 million for FY2024, which is 8.98% up from last year.
  • Per Guardant Health's latest filing, its Net Income towards Common Stockholders stood at -$92.7 million for Q3 2025, which was up 7.18% from -$99.9 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Net Income towards Common Stockholders ranged from a high of -$72.8 million in Q2 2023 and a low of -$229.4 million during Q2 2022.
  • For the 3-year period, Guardant Health's Net Income towards Common Stockholders averaged around -$109.4 million, with its median value being -$102.6 million (2024).
  • Per our database at Business Quant, Guardant Health's Net Income towards Common Stockholders crashed by 295.46% in 2021 and then surged by 68.28% in 2023.
  • Over the past 5 years, Guardant Health's Net Income towards Common Stockholders (Quarterly) stood at -$90.9 million in 2021, then tumbled by 53.92% to -$139.9 million in 2022, then plummeted by 33.67% to -$187.0 million in 2023, then skyrocketed by 40.65% to -$111.0 million in 2024, then grew by 13.95% to -$92.7 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$92.7 million for Q3 2025, versus -$99.9 million for Q2 2025 and -$95.2 million for Q1 2025.